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Abstract The ability of ubiquitin to form up to eight dif-
ferent polyubiquitin chain linkages generates complexity
within the ubiquitin proteasome system, and accounts for the
diverse roles of ubiquitinationwithin the cell. Understanding
how each type of ubiquitin linkage is correctly interpreted by
ubiquitin binding proteins provides important insights into
the link between chain recognition and cellular fate. Amajor
function of ubiquitination is to signal degradation of intra-
cellular proteins by the 26S proteasome. Lysine-48 (K48)
linked polyubiquitin chains are well established as the
canonical signal for proteasomal degradation, but recent
studies show a role for other ubiquitin linked chains in
facilitating degradation by the 26S proteasome. Here, we
review how different types of polyubiquitin linkage bind to
ubiquitin receptors on the 26S proteasome, how they signal
degradation and discuss the implications of ubiquitin chain
linkage in regulating protein breakdown by the proteasome.
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Introduction
Diversity in the ubiquitin system is generated by the ability
of ubiquitin to form eight different types of chains on itself
through its seven lysine (K) residues (K6, K11, K27, K29,
K33, K48, and K63) or N-terminus (Met-linked or linear).
Further complexity is generated by the formation of
polyubiquitin chains of uniform linkage (homotypic) or
mixed linkages (heterotypic). Each type of polyubiquitin
chain has the potential to act as a distinct intracellular
signal that must be specifically identified and decoded by
ubiquitin binding proteins (UBPs), to facilitate the diverse
outcomes of ubiquitination within cells (reviewed in [1]).
This is typically exemplified by the role of K48-polyu-
biquitin chains signalling proteasomal degradation, while
K63-polyubiquitin conjugates are involved in non-protea-
somal pathways, including intracellular signalling, DNA
repair, and the endosomal–lysosomal system.
Degradation of intracellular soluble proteins is princi-
pally mediated by the 26S proteasome. This 2.5 MDa
complex comprises the cylindrical 20S chamber, where
proteolysis occurs, and the 19S regulatory particle, which
binds polyubiquitinated proteins and governs their entry
into the 20S catalytic chamber. Through its six ATPase
subunits, the 19S complex catalyzes gate opening in the
20S outer ring, substrate unfolding, and translocation into
the 20S’s internal proteolytic chamber. Polyubiquitinated
substrates are recognized, tightly bound, and efficiently
degraded by the eukaryotic 26S through several carefully
integrated steps: (1) The initial binding step involves high
affinity ubiquitin receptor sites [19S subunits Rpn10 (S5a)
and Rpn13] [2–4]. This step is ATP-activated but is easily
reversible [2]. (2) Some chains then become more tightly
bound and committed to proteolysis, through a process
requiring both an unfolded domain within the ubiquitinated
protein and ATP hydrolysis [2]. (3) Proteins are deubiq-
uitinated by one or more of the 26S-associated
deubiquitinating enzymes (DUBs), Usp14, Uch37, or
Rpn11 [5]. (4) Finally, the protein is unfolded and
translocated through the opened gate of the 20S [6–8].
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While K48-linked polyubiquitin chains are established as
the canonical signal for proteasomal degradation, recent
studies highlight the ability of the proteasome to bind
monoubiquitinated proteins or other types of polyubiquitin
chains. Here, we discuss how ubiquitinated proteins bind to
the 26S proteasome, and focus on the ability of the protea-
some to distinguish between different polyubiquitin linkages.
Proteasome ubiquitin receptors
The outcome of polyubiquitination is dependent on recog-
nition of the ubiquitin chains by UBPs, which act as ubiquitin
receptors. These proteins usually encode several ubiquitin-
binding domains (UBDs) that may differ in their affinity and
avidity for distinct ubiquitin linkages. UBDs typically consist
of one or more a-helices that bind ubiquitin through a
hydrophobic region, centered on isoleucine-44 (I44). Most
UBDs of the a-helical class have relatively low affinities for
a single ubiquitin molecule, but micromolar affinities for
tetraubiquitin chains [9]. The presence of several UBDs
within the same protein not only increases the affinity for
polyubiquitin chains but can also change the avidity and
determines linkage selectivity (reviewed in [10]).
The first ubiquitin receptor identified within the 26S
proteasome was Rpn10 (S5a). Deveraux et al. used protea-
somes isolated from human red blood cells and observed that
the 19S subunit Rpn10 bound ubiquitinated lysozyme con-
jugates [11]. However, this was clearly not the only ubiquitin
receptor for the proteasome, as the deletion of Rpn10 in
saccharomyces cerevisiae had a modest phenotype and did
not affect viability [12]. Subsequent studies in yeast have
been instrumental in identifying other UBDs within other
intrinsic components of the proteasome, namely, Rpt5,
Rpn13, and Sem1 (Dss1) [4, 13, 14] (Fig. 1a; Table 1).
While all these subunits can bind polyubiquitinated proteins,
the relative contribution of each for facilitating proteasomal
degradation is unclear. However, biochemical assays of
ubiquitin binding and protein degradation show that the 19S
subunits, Rpn10 and Rpn13, are the high affinity ubiquitin
receptors for the proteasome (Fig. 1a) [2–4, 15].
In addition to the intrinsic 19S ubiquitin receptors, the
proteasome can bind polyubiquitinated substrates through
proteins that transiently associate with the 19S (Fig. 1b;
Table 1). Such proteins typically encode both ubiquitin like
(Ubl) domains and UBDs. The UBDs bind the polyubiq-
uitin chains, while the Ubl binds to the 19S high affinity
ubiquitin receptors or other 19S subunits (e.g., Rpn1) [16].
Yeast Rad23 was one of the first Ubl–UBD proteins shown
to bind polyubiquitinated proteins through its two UBA
(ubiquitin-associated) domains and deliver these conju-
gates to the proteasome for degradation [16, 17]. However,
the relative importance of Rad23 in recruiting polyubiq-
uitinated proteins to the proteasome has subsequently been
questioned, as although initial studies suggested that Rad23
and its human homologues (hHR23A and B) bind to
polyubiquitinated proteins and the proteasome [18, 19],
others found that Rad23 prevented protein degradation
[20]. It is likely that these differences in Rad23 function are
due to the protein concentration used in the in vitro assays
Fig. 1 Proteasome ubiquitin receptors. Schematic of the 26S protea-
some illustrating the position of the intrinsic proteasome receptors
(a) and the association of the UBA–Ubl proteins with the 19S
proteasome (b). Rpn10 and Rpn13 are the predominant high affinity
sites for binding ubiquitinated proteins. In yeast, Rpn1 may also
facilitate binding of ubiquitinated proteins to the 19S (a). Ubl–UBA
proteins, such as Rad23 and Dsk2, associate with the 26S through
their Ubl domains that bind to either Rpn10 or Rpn13. The UBA
domains bind the polyubiquitin chains (b)
G. L. Grice, J. A. Nathan
123
T
a
b
le
1
P
ro
te
as
o
m
e
u
b
iq
u
it
in
re
ce
p
to
rs
G
en
e
S
p
ec
ie
s
U
b
iq
u
it
in
b
in
d
in
g
d
o
m
ai
n
s
L
o
ca
ti
o
n
w
it
h
in
th
e
2
6
S
p
ro
te
as
o
m
e
A
ss
ig
n
ed
fu
n
ct
io
n
s
R
p
n
1
0
Y
ea
st
S
in
g
le
u
b
iq
u
it
in
-i
n
te
ra
ct
in
g
m
o
ti
f
(U
IM
)
d
o
m
ai
n
In
tr
in
si
c
1
9
S
su
b
u
n
it
,
b
u
t
ca
n
b
e
su
b
st
o
ic
h
io
m
et
ri
c
B
in
d
s
K
4
8
an
d
K
6
3
-p
o
ly
u
b
iq
u
it
in
ch
ai
n
s.
Y
ea
st
R
p
n
1
0
D
is
v
ia
b
le
an
d
re
q
u
ir
ed
fo
r
th
e
d
eg
ra
d
at
io
n
o
f
sp
ec
ifi
c
su
b
st
ra
te
s
(e
.g
.,
S
ic
1
)
in
co
n
ju
n
ct
io
n
w
it
h
R
ad
2
3
D
[2
9
]
R
p
n
1
0
/S
5
a
M
am
m
al
ia
n
T
w
o
U
IM
d
o
m
ai
n
s
In
tr
in
si
c
1
9
S
su
b
u
n
it
,
b
u
t
ca
n
b
e
su
b
st
o
ic
h
io
m
et
ri
c
B
in
d
s
K
4
8
an
d
K
6
3
-p
o
ly
u
b
iq
u
it
in
ch
ai
n
s
[2
].
D
o
es
n
o
t
b
in
d
h
o
m
o
ty
p
ic
K
1
1
-u
b
iq
u
it
in
ch
ai
n
s
[5
4
].
R
p
n
1
0
d
el
et
io
n
in
m
o
u
se
h
ep
at
o
cy
te
s
ca
u
se
s
m
il
d
li
v
er
im
p
ai
rm
en
t
[1
5
]
R
p
n
1
3
Y
ea
st
/m
am
m
al
ia
n
P
le
ck
st
ri
n
-l
ik
e
re
ce
p
to
r
o
f
u
b
iq
u
it
in
(P
R
U
)
d
o
m
ai
n
In
tr
in
si
c
1
9
S
su
b
u
n
it
B
in
d
s
K
4
8
an
d
K
6
3
-p
o
ly
u
b
iq
u
it
in
ch
ai
n
s
R
p
n
1
3
d
el
et
io
n
in
m
o
u
se
h
ep
at
o
cy
te
s
ca
u
se
s
m
il
d
li
v
er
im
p
ai
rm
en
t
[1
5
].
S
ev
er
e
li
v
er
d
is
ea
se
an
d
ac
cu
m
u
la
ti
o
n
o
f
u
b
iq
u
it
in
co
n
ju
g
at
es
is
o
b
se
rv
ed
w
it
h
d
el
et
io
n
o
f
b
o
th
R
p
n
1
0
an
d
R
p
n
1
3
[1
5
]
R
p
t5
Y
ea
st
/m
am
m
al
ia
n
N
o
t
k
n
o
w
n
In
tr
in
si
c
1
9
S
su
b
u
n
it
R
ep
o
rt
ed
to
b
in
d
u
b
iq
u
it
in
co
n
ju
g
at
es
u
si
n
g
cr
o
ss
li
n
k
in
g
ex
p
er
im
en
ts
[1
3
],
w
h
ic
h
m
ay
re
su
lt
fr
o
m
it
s
cl
o
se
p
ro
x
im
it
y
to
R
p
n
1
0
[7
4
]
D
ss
1
(S
em
1
)
Y
ea
st
U
n
st
ru
ct
u
re
d
u
b
iq
u
it
in
b
in
d
in
g
si
te
(U
B
S
)
P
ro
te
as
o
m
e
as
se
m
b
ly
B
in
d
s
p
o
ly
u
b
iq
u
it
in
co
n
ju
g
at
es
.
C
o
n
se
rv
ed
in
eu
k
ar
y
o
te
s,
b
u
t
it
s
u
b
iq
u
it
in
b
in
d
in
g
fu
n
ct
io
n
h
as
o
n
ly
b
ee
n
ex
am
in
ed
in
fi
ss
io
n
y
ea
st
[1
4
]
R
ad
2
3
Y
ea
st
T
w
o
U
B
A
d
o
m
ai
n
s
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
C
o
m
b
in
ed
R
ad
2
3
D
/D
sk
2
D
ca
u
se
s
ac
cu
m
u
la
ti
o
n
o
f
p
o
ly
u
b
iq
u
it
in
co
n
ju
g
at
es
an
d
re
p
o
rt
er
su
b
st
ra
te
s
in
y
ea
st
[7
5
]
h
H
R
2
3
A
M
am
m
al
ia
n
T
w
o
U
B
A
d
o
m
ai
n
s
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
0
/R
p
n
1
3
B
in
d
s
se
le
ct
iv
el
y
to
K
4
8
-p
o
ly
u
b
iq
u
it
in
co
n
ju
g
at
es
[2
1
]
h
H
R
2
3
B
M
am
m
al
ia
n
T
w
o
U
B
A
d
o
m
ai
n
s
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
0
/R
p
n
1
3
B
in
d
s
se
le
ct
iv
el
y
to
K
4
8
-p
o
ly
u
b
iq
u
it
in
co
n
ju
g
at
es
[2
1
].
h
H
R
2
3
A
an
d
B
h
av
e
d
if
fe
re
n
t
su
b
st
ra
te
s
in
m
am
m
al
ia
n
ce
ll
s
[1
9
]
D
sk
2
Y
ea
st
U
B
A
d
o
m
ai
n
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
0
/R
p
n
1
3
C
o
m
b
in
ed
R
ad
2
3
D
/D
sk
2
D
ca
u
se
s
ac
cu
m
u
la
ti
o
n
o
f
p
o
ly
u
b
iq
u
it
in
co
n
ju
g
at
es
an
d
re
p
o
rt
er
su
b
st
ra
te
s
in
y
ea
st
[7
5
]
U
B
Q
L
N
1
an
d
2
M
am
m
al
ia
n
U
B
A
d
o
m
ai
n
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
0
/R
p
n
1
3
M
u
ta
ti
o
n
s
in
U
B
Q
L
N
ar
e
as
so
ci
at
ed
w
it
h
M
N
D
[2
6
]
D
d
i1
Y
ea
st
/m
am
m
al
ia
n
U
B
A
d
o
m
ai
n
P
ro
te
as
o
m
e-
as
so
ci
at
ed
.
B
in
d
s
to
R
p
n
1
0
/R
p
n
1
3
U
b
l–
U
B
A
p
ro
te
in
th
at
m
ay
fu
n
ct
io
n
si
m
il
ar
ly
to
R
ad
2
3
[2
3
]
The recognition of ubiquitinated proteins by the proteasome
123
of proteasomal degradation. We found that when hHR23A
and B are used at concentrations similar to those found
in vivo, they stimulate the binding of K48-polyubiquiti-
nated proteins to mammalian proteasomes [21].
Several other Ubl–UBA proteins have been identified,
including Ddd1 [22, 23], Dsk2 [16, 24], and its human
homologues [hPLIC1 and 2, also known as Ubiquilin
(UBQLN1 and 2)] [25] (Table 1). The importance of these
proteins is highlighted by the identification of human
mutations causing neurological disease. Mutations in
UBQLN2 cause an X-linked form of motor neurone disease
[MND, or amyotrophic lateral sclerosis (ALS)] [26], while
mutations in UBQLN1 are associated with MND as well as
Alzheimer’s disease [27, 28]. These mutations are thought
to be pathogenic in part due to the accumulation of ubiq-
uitinated protein aggregates and defects in proteasomal
degradation [26].
With the relatively large number of known ubiquitin
receptors that are either encoded within the 19S or can
associate with the complex (Table 1), it is not surprising
that the deletions of individual UBPs may not alter viability
[29, 30]. However, it is likely that different proteasome-
associated UBPs bind distinct groups of polyubiquitinated
proteins, allowing for selective and specific protein
degradation. Indeed, Verma et al. show that while yeast
deletion of Rad23 and Rpn10 does not affect overall pro-
tein degradation, it does prevent the degradation of specific
proteasome substrates, such as Sic1 [29]. Similarly, in a
mammalian system, Hamazaki et al. show that liver-
specific deletion of either Rpn10 or Rpn13 results in
modest impairment of function, but the deletion of both
ubiquitin receptors causes severe liver injury and the
accumulation of polyubiquitin conjugates [15].
K48-polyubiquitin chains signal proteasome-
mediated degradation
K48-polyubiquitin chains are the most abundant linkage in
cells [31, 32], and are thought to be the major signal for
proteasome-mediated degradation [33, 34]. Quantitative
mass spectrometry analyses of intracellular ubiquitin link-
ages support this notion, as K48-polyubiquitin linkages
rapidly accumulate when cells are treated with the pro-
teasome inhibitor MG132 [32]. Biochemical studies
provided the first direct evidence for K48-polyubiquitin
chains binding to the 26S proteasome and stimulating
protein degradation [33, 35]. Subsequently, Thrower et al.
identified a chain of four or more K48-linked ubiquitins as
the optimal chain length to stimulate protein degradation
[35]. However, recent studies suggest that the number of
K48-polyubiquitin chains may be more important than the
chain length. In elegant proteasomal degradation assays
and single molecule kinetic studies, Lu et al. demonstrate
that multiple ubiquitinated lysines are more efficient than
K48-polyubiquitin chains in stimulating proteasomal
degradation [36]. They observed rapid degradation of the
cell-cycle protein, cyclin B1, when modified with two
diubiquitin K48-chains as compared with a single
tetraubiquitin K48-chain [36]. It should be noted that
human proteasomes used in these assays were salt washed
to remove the DUB USP14 and associated proteins (in-
cluding hHR23A and B). Whether Ubl–UBA proteins
affect the degradation of ubiquitinated proteins modified
with several K48-linked chains remains to be determined.
Biochemical assays confirm that K48-polyubiquitin
conjugates initially bind to the proteasome through Rpn10
and Rpn13 (Fig. 2a). Proteasomes purified from yeast
strains that lack UBDs in Rpn10 and Rpn13 (rpn10DUIM,
rpn13KKD, or rpn10DUIM/rpn13KKD) show reduced
affinity for K48-polyubiquitin conjugates, with a fourfold
decrease in affinity for the double mutant [2]. However,
some K48-polyubiquitin conjugates still bind to protea-
somes in these Rpn10/Rpn13 mutants, indicating the
presence of lower affinity ubiquitin receptors for polyu-
biquitin chains [2].
Because K48-polyubiquitin chains are the major signal
for proteasome-mediated degradation, it was possible that
the intrinsic proteasome ubiquitin receptors selectively bind
K48-linked chains. This is clearly not the case, as pure
proteasomes bind K48- and K63-linked chains similarly,
through the same high affinity Rpn10 and Rpn13 ubiquitin
receptors [2, 37, 38]. However, Ubl–UBA proteins, such as
Rad23, do show selectivity for K48-polyubiquitin chains.
The second UBA domain of Rad23 has a higher affinity for
K48-tetraubiquitin compared with K63-tetraubiquitin [39].
In addition, we found that full-length hHR23A and hHR23B
bind only to K48-polyubiquitin conjugates when compared
with K63-polyubiquitin chains [21]. Furthermore, full-length
hHR23A and, particularly, hHR23B selectively stimulate
K48-polyubiquitin conjugates binding to the 26S protea-
some [21]. Therefore, the Rad23 proteins do provide
ubiquitin linkage specificity for delivering K48-polyubiqui-
tinated proteins to the proteasome. Whether other
proteasome-associated ubiquitin receptors share the same
specificity for K48-linkages remains to be determined.
K63-polyubiquitin chains bind to pure
proteasomes but do not signal degradation in cells
K63-polyubiquitin linkages are also highly abundant in
cells [31, 32], but serve alternative functions to protea-
some-mediated degradation, and are involved in
intracellular signalling [40], DNA repair [41], and the
targeting of proteins to the endosomal–lysosomal system
G. L. Grice, J. A. Nathan
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[42]. One could, therefore, hypothesise that K63-polyu-
biquitinated proteins cannot bind to the proteasome.
However, as previously mentioned, K63-polyubiquitin
conjugates do not only bind pure 26S proteasomes [2, 21]
in vitro, but can also stimulate protein degradation at
similar rates to K48-polyubiquitinated substrates [37, 38].
Three mechanisms could explain this discrepancy
between the function of K63-polyubiquitinated chains in
cells and their ability to signal proteasome-mediated
degradation in vitro: (1) K63-polyubiquitin chains are
rapidly disassembled in cells preventing their association
with the 26S proteasome. (2) K48-polyubiquitin chains are
more efficiently delivered to the proteasome by proteins,
such as hHR23B, and (3) K63-polyubiquitin chains are
blocked from binding the 19S by intracellular factors.
Several groups have examined which of these mechanisms
may account for preventing the degradation of K63-
polyubiquitin conjugates in cells.
Cooper et al. found that K63-polyubiquitin conjugates in
cell lysates were rapidly disassembled compared with K48-
chains, and identified the BRISC (Brcc36 isopeptidase
complex) as the DUB responsible for this observation [43].
Jacobson et al. also found that K63-polyubiquitin chains
are more rapidly disassembled by the proteasome-associ-
ated DUBs [31]. The proteasome DUB Rpn11 (Poh1) and
BRISC are members of the JAMM/MPN? (Jab1/Mov34/
Mpr1 Pad1 N-terminal?) proteases, and it has been sug-
gested that this group of DUBs shows a preference for
Fig. 2 Recognition of different ubiquitin linkages by the 26S
proteasome. Schematic of the interaction of the 26S proteasome with
different types of ubiquitin linkages. The positions of Rpn13 and
Rpn10 within the proteasome are highlighted (dark blue). K48-
polyubiquitinated proteins are the canonical signal for proteasome-
mediated degradation (a). K63-polyubiquitin chains are blocked from
binding to the 26S due to K63-selective ubiquitin binding proteins,
which bind tightly to the K63-polyubiquitin chains and direct them to
alternative pathways (endosomal–lysosomal pathway) (b). Homo-
typic K11-polyubiquitin chains do not bind tightly to the 19S
proteasome receptors (c). Heterotypic K11/K48-polyubiquitinated
proteins signal proteasome-mediated degradation of cell-cycle sub-
strates (e.g., cyclin B1) (d). Multiple monoubiquitination can
facilitate the degradation of some proteasome substrates (cyclin B1)
(e). Short proteins (less than 150 amino acids) may be targeted for
degradation by a single ubiquitin moiety (f). Ub ubiquitin
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K63-polyubiquitin chains [43]. However, it is unlikely that
rapid disassembly of K63-conjugates provides the major
mechanism for protecting K63-polyubiquitinated proteins,
as the binding of polyubiquitin chains to the high affinity
proteasome ubiquitin receptors precedes DUB activation.
Furthermore, by measuring conjugate binding at 4 C, we
showed that both K48- and K63-polyubiquitin conjugates
bind similarly, and we observed no difference in this
binding when DUB inhibitors were added [21].
To identify factors in cells that may prevent K63-
polyubiquitin chains from binding to the proteasome, we
used a biochemical and mass spectrometry approach.
Several proteins that bound strongly to K63-polyubiquitin
conjugates were identified, including the ESCRT0 proteins
[21]. This heterodimeric complex recruits polyubiquiti-
nated proteins to the endosomal–lysosomal pathway
(reviewed in [44]), but is also present within the cytosol
[21]. We found that ESCRT0 not only selectively bound to
K63-polyubiquitin chains, but also prevented these conju-
gates from binding to pure proteasomes. Thus, K48-
selective Ubl–UBA proteins (e.g., hHR23B) stimulate
K48-polyubiquitin conjugates binding to the proteasome,
and K63-polyubiquitin chains are protected from protea-
somal degradation by K63-linkage-specific UBPs, such as
ESCRT0 (Fig. 2b) [21].
Homotypic K11-polyubiquitin chains do not bind
to the proteasome
K11-linked polyubiquitin chains are the third most abun-
dant linkages in cells [32], and have a unique structure
compared with K48, K63, or linear-linked chains [45]. The
most well characterized role for K11-linkages is in the cell
cycle. In mitosis, the anaphase promoting complex/cyclo-
some (APC/C) E3 ligase catalyzes polyubiquitin chain
formation on cell-cycle proteins (e.g., cyclin B1 and
securin) signalling the degradation of these mitotic regu-
lators [46, 47]. K11-chains have also been shown to
accumulate in cells released from mitotic arrest, when the
APC/C is most active [48]. In vitro studies have identified
that several E2 enzymes are required for the ubiquitination
of APC/C substrates. Either UbcH10 or UbcH5 is required
to initiate ubiquitination of cyclin B1, and the polyubiq-
uitin chain formed is then extended by the K11-specific E2
enzyme Ube2S [48, 49]. It was, therefore, initially thought
that K11-chains were required for the degradation of cell-
cycle checkpoint proteins. Interestingly though, knock-
down of Ube2S by siRNA-depletion in HeLa cells only
delayed exit from mitosis when drug-induced perturbations
(e.g., monastrol) of the cell cycle were used, and Ube2S
was not required for normal mitosis [49]. In addition,
Ube2S is not necessary for degradation of ubiquitinated
cyclin B1, as multiple monoubiquitination of cyclin B1 was
sufficient to initiate its proteasome-mediated degradation
[36, 50].
In contrast to the presumed proteasome-mediated
degradative role of K11-linkages in the cell cycle, K11-
polyubiquitination has been observed in other cellular
processes, including ER-associated degradation (ERAD)
[32], the hypoxia response [51], mitophagy [52], and even
in stabilizing proteins, such as b-catenin [53].
Using pure 26S proteasomes and homotypic K11-
polyubiquitin conjugates, we examined whether these
chains facilitated proteasomal degradation. Surprisingly,
we found that homotypic K11-chains did not bind to pure
proteasomes or to the proteasome-associated ubiquitin
receptors (Fig. 2c) [54]. In addition, homotypic K11-
polyubiquitin chains did not facilitate the rapid degradation
of cyclin B1. The finding that homotypic K11-polyubiq-
uitination does not signal proteasomal degradation has
been subsequently observed by Martinez-Fonts et al, who
used a fluorescent-based proteasomal degradation assay of
K11-polyubiquitinated GFP [55].
We also examined the binding of homotypic K11-
polyubiquitin chains to the 19S ubiquitin receptors and
Ubl–UBA proteins. Consistent with K11-polyubiquitin
chains being a weak signal for proteasomal degradation, we
observed no significant binding of homotypic K11-chains
to Rpn10, hHR23A, hHR23B, or UBQLN1 [54]. Other
groups have examined the direct binding of UBDs within
proteasome-associated ubiquitin receptors and K11-chains.
Castaneda et al. show that the UBA2 domain of hHR23A
binds K48 dimers more strongly than K11-ubiquitin dimers
[45]. It appears that a single molecule of UBA cannot
interact with both hydrophobic regions of the K11-ubiq-
uitin dimers at the same time. This is not the case for K48
ubiquitin dimers, which can associate with a single UBA
moiety [45]. The compact K11-ubiquitin dimer formation
and orientation of the two ubiquitin molecules may prevent
the I44 hydrophobic region being available to the protea-
somal ubiquitin receptors, hence explaining the weak
binding of these chains in comparison with K48-ubiquitin
linkages [54].
Heterotypic K11/K48-polyubiquitin chains signal
proteasome-mediated degradation
It is likely that the diverse fates of K11-polyubiquitinated
proteins relates to the homotypic or heterotypic confor-
mation of the chain. Recent studies show that the APC/C
forms heterotypic K11/K48-chains on cell-cycle substrates
(Nek2A and cyclin A), rather than homotypic K11-chains
[56]. Mayer et al. observed that these heterotypic chains
were more efficient at stimulating the degradation of the
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cell-cycle substrates compared with homotypic K48-
polyubiquitin chains (Fig. 2d) [56]. While we also found
that heterotypic K11/K48-polyubiquitin chains bind to the
proteasome and signal degradation, they were not as effi-
cient as homotypic K48-polyubiquitin chains [54]. The
reason for this discrepancy may relate to the experimental
conditions and our use of recombinant APC/C rather than
APC/C immunoprecipitated from cell extracts.
The ability of the proteasome to differentially degrade
homotypic and heterotypic K11-polyubiquitin conjugates
may also relate to disassembly of the chains by the pro-
teasome-associated DUBs. We observed that K11/K48-
heterotypic chains were disassembled slowly compared
with the K11-homotypic chains [54]. Mansour et al. also
found that K11-polyubiquitin chains were rapidly disas-
sembled by the proteasome-associated DUBs compared
with K48-chains. How the heterotypic chains bind and
interact with the proteasome-associated DUBs is unclear.
Furthermore, whether K11-heterotypic chains containing
other lysine linkages can be disassembled by these DUBs,
or stimulate proteasomal degradation is not known. How-
ever, it is noteworthy that complex polyubiquitin chains,
containing forked chains of mixed linkages have been
reported to block proteasomal degradation [57].
Monoubiquitination as a signal for proteasome-
mediated degradation
Monoubiquitination is typically involved in subcellular
localization of proteins [58] or signalling the internaliza-
tion of plasma membrane receptors, rather than facilitating
degradation [59]. However, the requirement for a polyu-
biquitin chain of four or more ubiquitin moieties has been
challenged by several recent studies. Dimova et al. showed
that multiple monoubiquitination of cyclin B1 is an effi-
cient signal for proteasomal degradation in Xenopus
extracts (Fig. 2e) [50]. Lu et al. confirm that multiple
monoubiquitination of cyclin B1 is sufficient to stimulate
degradation by human proteasomes using single molecule
kinetic studies [36]. However, multiple monoubiquitination
of other cell-cycle substrates (geminin and securin) did not
facilitate rapid proteasomal degradation [36]. The distri-
bution and conformation of the multi-monoubiquitinated
protein may be important for binding to the proteasome
ubiquitin receptors. In addition, the position of unfolded
regions within the ubiquitinated substrate will contribute to
the rate of proteasomal degradation [60]. Indeed, Shabek
et al. show that a single ubiquitin fused to an approximately
150 amino acid polypeptide (repeat HA tag) was sufficient
to signal proteasomal degradation (Fig. 2f) [61]. However,
ubiquitin fused to polypeptides longer than 150 amino
acids were degraded slowly.
What is the role of other ubiquitin linkages
in signalling proteasomal degradation?
Whether the other ubiquitin linkages that occur in cells can
mediate proteasomal degradation is largely unknown.
Linear chains are structurally similar to K63-polyubiquitin
chains, and appear confined to NF-jB signalling [62].
UBPs, such as NEMO (NF-jB essential modulator),
selectively bind linear chains [63], and may prevent them
binding to the proteasome, similarly to ESCRT0 and K63-
polyubiquitin chains [21].
While K6, K27, K29, and K33 ubiquitin linkages are all
detected at low levels in cells, they do all increase to
varying extents when cells are treated with proteasome
inhibitors [32]. This suggests that they may be involved in
proteasome-mediated degradation, but not necessarily in
homotypic conformations. However, the role of these
ubiquitin linkages in cells remains unclear. K6 and K27
linkages are associated with DNA replication repair [64,
65], while K29 and K33 are hydrolyzed by the DUB
involved in Wnt signalling (TRABID) [66]. Structural
analyses of dimeric forms of these atypical ubiquitin
linkages reveal distinct conformations [67–69], suggesting
that they can form unique ubiquitin signals. Whether they
have a role in proteasome-mediated degradation remains to
be determined.
Future perspectives
Advances in biochemical techniques and single molecule
kinetics will offer further mechanistic insights into ubiq-
uitin recognition by the 26S proteasome. Particularly, the
ability to form different polyubiquitin linked chains of
defined length will help to elucidate the role of atypical
ubiquitin linkages in proteasome-mediated degradation.
However, determining the type and number of ubiquitin
chains that occur on individual protein substrates in cells
remains a challenge. Post-translational modifications of
ubiquitin and its receptors add a further level of complexity
to the system. For example, phosphorylation of ubiquitin at
serine 65 (S65) by PTEN-induced putative kinase 1
(PINK1) is required for the clearance of damaged mito-
chondria [70–72]. While S65 phosphorylated ubiquitin can
be incorporated into different polyubiquitin chains [73], the
role of the proteasome in degrading such conjugates is not
known. It will be of interest to examine how S65 phos-
phorylation and other modifications of ubiquitin are
involved in proteasome-mediated degradation.
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